• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

G. Scott Gazelle, MD, MPH, PhD


  • Harvey HB, Alkasab TK, Pandharipande PV, Zhao J, Halpern EF, Salazar GM, Abujudeh HH, Rosenthal DI, Gazelle GS.
    Radiologist compliance with institutional guidelines for use of nonroutine communication of diagnostic imaging results.
    J Am Coll Radiol. 2015 Apr;12(4):376-84.
  • Romanus D, Cardarella S, Cutler D, Landrum MB, Lindeman NI, Gazelle GS.
    Cost-effectiveness of multiplexed predictive biomarker screening in non-small-cell lung cancer.
    J Thorac Oncol. 2015 Apr;10(4):586-94.
  • Glover M, Khalilzadeh O, Choy G, Prabhakar AM, Pandharipande PV, Gazelle GS.
    Hospital Evaluations by Social Media: A Comparative Analysis of Facebook Ratings among Performance Outliers.
    J Gen Intern Med. 2015 Mar 7.
  • Lowry KP, Gazelle GS, Gilmore ME, Johanson C, Munshi V, Choi SE, Tramontano AC, Kong CY, McMahon PM.
    Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.
    Cancer. 2015 Feb 3.
  • Niell BL, Bennett D, Sharma A, Gazelle GS.
    Extramammary Findings on Breast MR Examinations: Frequency, Clinical Relevance, and Patient Outcomes.
    Radiology. 2015 Jan 13:141539.
  • Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, Gazelle GS, Weinstein MC.
    Annual financial impact of well-differentiated thyroid cancer care in the United States.
    Cancer. 2014 May 1;120(9):1345-52.
  • Tramontano AC, Cipriano LE, Kong CY, Shepard JA, Lanuti M, Gazelle GS, McMahon PM.
    Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.
    AJR Am J Roentgenol. 2013 May;200(5):1020-7.
  • Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS.
    Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.
    Cancer. 2013 Mar 15;119(6):1266-76.
  • Pandharipande PV, Eisenberg JD, Lee RJ, Gilmore ME, Turan EA, Singh S, Kalra MK, Liu B, Kong CY, Gazelle GS.
    Patients with testicular cancer undergoing CT surveillance demonstrate a pitfall of radiation-induced cancer risk estimates: the timing paradox.
    Radiology. 2013 Mar;266(3):896-904.
  • Knudsen AB, Hur C, Gazelle GS, Schrag D, McFarland EG, Kuntz KM.
    Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.
    Ann Intern Med. 2012 Nov 6;157(9):611-20.
  • Hartman RI, Chang CY, Wo JY, Eisenberg JD, Hong TS, Harisinghani MG, Gazelle GS, Pandharipande PV.
    Optimizing Adjuvant Treatment Decisions for Stage T2 Rectal Cancer Based on Mesorectal Node Size: A Decision Analysis.
    Acad Radiol. 2012 Sep 1.
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS.
    Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.
    Risk Anal. 2012 Jul;32 Suppl 1:S117-24.
  • Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS.
    Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.
    Oncologist. 2011;16(1):121-32.
  • Abujudeh HH, Kaewlai R, McMahon PM, Binder W, Novelline RA, Gazelle GS, Thrall JH.
    Abdominopelvic CT increases diagnostic certainty and guides management decisions: a prospective investigation of 584 patients in a large academic medical center.
    AJR Am J Roentgenol. 2011 Feb;196(2):238-43.
  • Cipriano LE, Romanus D, Earle CC, Neville BA, Halpern EF, Gazelle GS, McMahon PM.
    Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
    Value Health. 2011 Jan;14(1):41-52.
  • Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C.
    The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.
    Diseases Of The Esophagus : Official Journal Of The International Society For Diseases Of The Esophagus / I.S.D.E. 2010 Aug;23(6):451-7.
  • Pandharipande PV, Gervais DA, Hartman RI, Harisinghani MG, Feldman AS, Mueller PR, Gazelle GS.
    Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.
    Radiology. 2010 Sep;256(3):836-46.
  • Ho W, Broughton DE, Donelan K, Gazelle GS, Hur C.
    Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population.
    AJR Am J Roentgenol. 2010 Aug;195(2):393-7.
  • Abujudeh HH, Boland GW, Kaewlai R, Rabiner P, Halpern EF, Gazelle GS, Thrall JH.
    Abdominal and pelvic computed tomography (CT) interpretation: discrepancy rates among experienced radiologists.
    Eur Radiol. 2010 Aug;20(8):1952-7.
  • Blankstein R, Murphy MK, Nasir K, Gazelle GS, Batlle JC, Al-Mallah M, Shturman L, Hoffmann U, Cury RC, Abbara S, Brady TJ, Lee TH.
    Perceived usefulness of cardiac computed tomography as assessed by referring physicians and its effect on patient management.
    Am J Cardiol. 2010 May 1;105(9):1246-53.
  • Hur C, Hayeck TJ, Yeh JM, Richards EB, Spechler SJ, Gazelle GS, Kong CY.
    Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma.
    PLoS ONE. 2010;5(3):e9483.
  • Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS.
    Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
    Radiology. 2010 Mar;254(3):793-800.
  • Huang ES, Gazelle GS, Hur C.
    Consensus Guidelines in the Management of Branch Duct Intraductal Papillary Mucinous Neoplasm: A Cost-Effectiveness Analysis.
    Dig Dis Sci. 2010 Mar;55(3):852-60.
  • Ladapo JA, Jaffer FA, Hoffmann U, Thomson CC, Bamberg F, Dec W, Cutler DM, Weinstein MC, Gazelle GS.
    Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain.
    J Am Coll Cardiol. 2009 Dec 15;54(25):2409-22.
  • Pandharipande PV, Gazelle GS.
    Comparative effectiveness research: what it means for radiology.
    Radiology. 2009 Dec;253(3):600-5.
  • Kong CY, McMahon PM, Gazelle GS.
    Calibration of disease simulation model using an engineering approach.
    Value Health. 2009 Jun;12(4):521-9.
  • Geisler BP,Siebert U,Gazelle GS,Cohen DJ,Gohler A.
    Deterministic Sensitivity Analysis for First-Order Monte Carlo Simulations: A Technical Note.
    Value Health.;12(1):96-7.
  • Ladapo JA, Horwitz JR, Weinstein MC, Gazelle GS, Cutler DM.
    Adoption and spread of new imaging technology: a case study.
    Health Aff (Millwood).;28(6):w1122-32.
  • Lee JM, Halpern EF, Rafferty EA, Gazelle GS.
    Evaluating the correlation between film mammography and MRI for screening women with increased breast cancer risk.
    Acad Radiol. 2009 Nov;16(11):1323-8. Review.
  • Greenblatt WH, Hur C, Knudsen AB, Evans JA, Chung DC, Gazelle GS.
    Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis.
    Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2677-84.
  • Hur C,Broughton DE,Kong CY,Ozanne EM,Richards EB,Truong T,Gazelle GS.
    Patient Preferences for the Chemoprevention of Colorectal Cancer.
    Dig Dis Sci. 2009 Oct;54(10):2207-14.
  • Pandharipande PV, Mora JT, Uppot RN, Goehler A, Braschi M, Halpern EF, Gazelle GS, Harisinghani MG.
    Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
    AJR Am J Roentgenol. 2009 Sep;193(3):W230-7.
  • Kahlon P, McCullough K, Gazelle GS.
    Enhancing patient safety: standardization of CT contrast media practices.
    J Am Coll Radiol. 2009 Aug;6(8):562-6.
  • Geisler BP, van Dam RM, Gazelle GS, Goehler A.
    Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure.
    Heart. 2009 Aug;95(15):1278-9; author reply 1279.
  • Pandharipande PV,Choy G,del Carmen MG,Gazelle GS,Russell AH,Lee SI.
    MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.
    AJR Am J Roentgenol. 2009 Mar;192(3):802-14.
  • Pearson SD,Knudsen AB,Scherer RW,Weissberg J,Gazelle GS.
    Assessing the comparative effectiveness of a diagnostic technology: CT colonography.
    Health Aff (Millwood). 2008 Nov-Dec;27(6):1503-14.
  • McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE, Weeks JC, Gazelle GS.
    Adopting helical CT screening for lung cancer : potential health consequences during a 15-year period.
    Cancer. 2008 Dec 15;113(12):3440-9.
  • Pandharipande PV,Harisinghani MG,Ozanne EM,Specht MC,Hur C,Lee JM,Gazelle GS.
    Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis.
    AJR Am J Roentgenol. 2008 Nov;191(5):1308-19.
  • Hur C,Broughton DE,Ozanne E,Yachimski P,Nishioka NS,Gazelle GS.
    Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus.
    Am J Gastroenterol. 2008 Oct;103(10):2432-42.
  • McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Kuntz KM, Shepard JA, Swensen SJ, Gazelle GS.
    Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study.
    Radiology. 2008 Jul;248(1):278-87.
  • Pandharipande PV, Gervais DA, Mueller PR, Hur C, Gazelle GS.
    Radiofrequency Ablation versus Nephron-sparing Surgery for Small Unilateral Renal Cell Carcinoma: Cost-effectiveness Analysis.
    Radiology. 2008 Jul;248(1):169-78.
  • Lee JM,Georgian-Smith D,Gazelle GS,Halpern EF,Rafferty EA,Moore RH,Yeh ED,D'Alessandro HA,Hitt RA,Kopans DB.
    Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.
    Radiology. 2008 Aug;248(2):398-405.
  • Lee JM, Kopans DB, McMahon PM, Halpern EF, Ryan PD, Weinstein MC, Gazelle GS.
    Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis.
    Radiology. 2008 Mar;246(3):763-71.
  • Gazelle G.
    Understanding hospice--an underutilized option for life's final chapter.
    N Engl J Med. 2007 Jul 26;357(4):321-4.
  • Hur C, Chung DC, Schoen RE, Gazelle GS.
    The management of small polyps found by virtual colonoscopy: results of a decision analysis.
    Clin Gastroenterol Hepatol. 2007 Feb;5(2):237-44.
  • Knudsen AB, McMahon PM, Gazelle GS.
    Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
    J Clin Oncol. 2007 Jan 10;25(2):203-8. Review.
  • McMahon PM, Zaslavsky AM, Weinstein MC, Kuntz KM, Weeks JC, Gazelle GS.
    Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.
    Med Decis Making. 2006 Sep-Oct;26(5):497-511.
  • Hur C, Wittenberg E, Nishioka NS, Gazelle GS.
    Quality of life in patients with various Barretts esophagus associated health states.
    Health Qual Life Outcomes. 2006 Aug 2;4(1):45.
  • Rodríguez JR, Germes SS, Pandharipande PV, Gazelle GS, Thayer SP, Warshaw AL, Fernández-del Castillo C.
    Implications and cost of pancreatic leak following distal pancreatic resection.
    Arch Surg. 2006 Apr;141(4):361-5; discussion 366.
  • Sahani DV, Kadavigere R, Blake M, Fernandez-Del Castillo C, Lauwers GY, Hahn PF.
    Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
    Radiology. 2006 Feb;238(2):560-9.
  • Hur C, Gazelle GS, Hsu EH, Halpern EF, Podolsky DK.
    The effect of prior colonic imaging on endoscopic productivity: potential impact of computed tomographic colonography.
    Clin Gastroenterol Hepatol. 2005 Nov;3(11):1124-7.
  • Gazelle GS, McMahon PM, Siebert U, Beinfeld MT.
    Cost-effectiveness analysis in the assessment of diagnostic imaging technologies.
    Radiology. 2005 May;235(2):361-70.
  • Hur C, Wittenberg E, Nishioka NS, Gazelle GS.
    Patient preferences for the management of high-grade dysplasia in Barrett's esophagus.
    Dig Dis Sci. 2005 Jan;50(1):116-25.
  • Neumann PJ, Divi N, Beinfeld MT, Levine BS, Keenan PS, Halpern EF, Gazelle GS.
    Medicare's national coverage decisions, 1999-2003: quality of evidence and review times.
    Health Aff (Millwood). 2005 Jan-Feb;24(1):243-54.
  • Hur C, Simon LS, Gazelle GS.
    Analysis of aspirin-associated risks in healthy individuals.
    Ann Pharmacother. 2005 Jan;39(1):51-7.
  • Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC.
    Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.
    Radiology. 2004 Dec;233(3):729-39.
  • Roberts TG, Goulart BH, Squitieri L, Stallings SC, Halpern EF, Chabner BA, Gazelle GS, Finkelstein SN, Clark JW.
    Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.
    JAMA. 2004 Nov 3;292(17):2130-40.
  • Hur C, Gazelle GS, Zalis ME, Podolsky DK.
    An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand.
    Gastroenterology. 2004 Nov;127(5):1312-21.
  • Earle CC, Kwok A, Gazelle GS, Fuchs CS.
    Two schedules of second-line irinotecan for metastatic colon carcinoma.
    Cancer. 2004 Dec 1;101(11):2533-9.
  • Hur C, Simon LS, Gazelle GS.
    The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals.
    Cancer. 2004 Jul 1;101(1):189-97.
  • Hur C, Nishioka NS, Gazelle GS.
    Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.
    J Natl Cancer Inst. 2004 Feb 18;96(4):316-25.
  • Gazelle GS, Seltzer SE, Judy PF.
    Assessment and validation of imaging methods and technologies.
    Acad Radiol. 2003 Aug;10(8):894-6.
  • Hur C, Nishioka NS, Gazelle GS.
    Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia.
    Dig Dis Sci. 2003 Jul;48(7):1273-83.
  • Hunink MG, Gazelle GS.
    CT screening: a trade-off of risks, benefits, and costs.
    J Clin Invest. 2003 Jun;111(11):1612-9.
  • Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS.
    Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Cancer. 2003 Jun 15;97(12):3027-35.
  • Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M, Lester JS, Tanabe KK, Weinstein MC.
    Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.
    Ann Surg. 2003 Apr;237(4):544-55.
  • Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN.
    Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.
    Radiology. 2003 Feb;226(2):441-51.
  • Halpern EF, Gazelle GS.
    Probability in radiology.
    Radiology. 2003 Jan;226(1):12-5.
  • Bosch JL, Halpern EF, Gazelle GS.
    Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication.
    Med Decis Making. 2002 Sep-Oct;22(5):403-9.
  • McMahon PM, Gazelle GS.
    Colorectal cancer screening issues: a role for CT colonography?.
    Abdom Imaging. 2002 May-Jun;27(3):235-43.
  • Shaffer DW, Kigin CM, Kaput JJ, Gazelle GS.
    What is digital medicine?.
    Stud Health Technol Inform. 2002;80:195-204.
  • Gazelle GS, Dunnick NR.
    Subsidizing radiology research.
    Acad Radiol. 2002 Feb;9(2):195-7.
  • Goldberg SN, Girnan GD, Lukyanov AN, Ahmed M, Monsky WL, Gazelle GS, Huertas JC, Stuart KE, Jacobs T, Torchillin VP, Halpern EF, Kruskal JB.
    Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.
    Radiology. 2002 Mar;222(3):797-804.
  • McMahon PM, Halpern EF, Fernandez-del Castillo C, Clark JW, Gazelle GS.
    Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectability.
    Radiology. 2001 Oct;221(1):93-106.
  • McMahon PM, Bosch JL, Gleason S, Halpern EF, Lester JS, Gazelle GS.
    Cost-effectiveness of colorectal cancer screening.
    Radiology. 2001 Apr;219(1):44-50.
  • Gazelle GS, Goldberg SN, Solbiati L, Livraghi T.
    Tumor ablation with radio-frequency energy.
    Radiology. 2000 Dec;217(3):633-46.
  • McMahon PM, Araki SS, Neumann PJ, Harris GJ, Gazelle GS.
    Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease.
    Radiology. 2000 Oct;217(1):58-68.
  • Halpern EF, Weinstein MC, Hunink MG, Gazelle GS.
    Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients.
    Med Decis Making. 2000 Jul-Sep;20(3):314-22.
  • Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK.
    Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.
    Cancer. 2000 Jun 1;88(11):2452-63.
  • Goldberg SN, Gazelle GS, Mueller PR.
    Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance.
    AJR Am J Roentgenol. 2000 Feb;174(2):323-31.
  • Goldberg SN, Hahn PF, Halpern EF, Fogle RM, Gazelle GS.
    Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter.
    Radiology. 1998 Dec;209(3):761-7.
  • Goldberg SN, Hahn PF, McGovern FJ, Fogle RM, Mueller PR, Gazelle GS.
    Benign prostatic hyperplasia: US-guided transrectal urethral enlargement with radio frequency--initial results in a canine model.
    Radiology. 1998 Aug;208(2):491-8.
  • Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR.
    Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature.
    AJR Am J Roentgenol. 1998 Jul;171(1):201-4.
  • Goldberg SN, Gazelle GS, Solbiati L, Livraghi T, Tanabe KK, Hahn PF, Mueller PR.
    Ablation of liver tumors using percutaneous RF therapy.
    AJR Am J Roentgenol. 1998 Apr;170(4):1023-8.
  • Lewin JS, Connell CF, Duerk JL, Chung YC, Clampitt ME, Spisak J, Gazelle GS, Haaga JR.
    Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility.
    J Magn Reson Imaging. 1998 Jan-Feb;8(1):40-7.
  • Steiner P, Botnar R, Dubno B, Zimmermann GG, Gazelle GS, Debatin JF.
    Radio-frequency-induced thermoablation: monitoring with T1-weighted and proton-frequency-shift MR imaging in an interventional 0.5-T environment.
    Radiology. 1998 Mar;206(3):803-10.
  • Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI.
    Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume.
    Acad Radiol. 1995 May;2(5):399-404.
  • Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI.
    Tissue ablation with radiofrequency using multiprobe arrays.
    Acad Radiol. 1995 Aug;2(8):670-4.
  • Gazelle GS, Wolf GL, McIntire GL, Bacon ER, Na G, Halpern EF, Toner JL.
    Hepatic imaging with iodinated nanoparticles: a comparison with iohexol in rabbits.
    Acad Radiol. 1995 Aug;2(8):700-4.
  • Goldberg SN, Gazelle GS, Compton CC, McLoud TC.
    Radiofrequency tissue ablation in the rabbit lung: efficacy and complications.
    Acad Radiol. 1995 Sep;2(9):776-84.
  • De Sanctis JT, Lee MJ, Gazelle GS, Boland GW, Halpern EF, Saini S, Mueller PR.
    Prognostic indicators in acute pancreatitis: CT vs APACHE II.
    Clin Radiol. 1997 Nov;52(11):842-8.
  • Steiner P, Botnar R, Goldberg SN, Gazelle GS, Debatin JF.
    Monitoring of radio frequency tissue ablation in an interventional magnetic resonance environment. Preliminary ex vivo and in vivo results.
    Invest Radiol. 1997 Nov;32(11):671-8.
  • Solbiati L, Goldberg SN, Ierace T, Livraghi T, Meloni F, Dellanoce M, Sironi S, Gazelle GS.
    Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes.
    Radiology. 1997 Nov;205(2):367-73.
  • Goldberg SN, Ryan TP, Hahn PF, Schima W, Dawson SL, Lawes KR, Mueller PR, Gazelle GS.
    Transluminal radiofrequency tissue ablation with use of metallic stents.
    J Vasc Interv Radiol. 1997 Sep-Oct;8(5):835-43.
  • Hahn PF, Gazelle GS, Jiang DY, Compton CC, Goldberg SN, Mueller PR.
    Liver tumor ablation: real-time monitoring with dynamic CT.
    Acad Radiol. 1997 Sep;4(9):634-8.
  • McDowell RK, Gazelle GS, Murphy BL, Boland GW, Mayo-Smith WW, Warshaw AL, Mueller PR.
    Mucinous ductal ectasia of the pancreas.
    J Comput Assist Tomogr. 1997 May-Jun;21(3):383-8.
  • Goldberg MA, Gazelle GS, Boland GW, Hahn PF, Mayo-Smith WW, Pivovarov M, Halpern EF, Wittenberg J.
    Focal hepatic lesions: effect of three-dimensional wavelet compression on detection at CT.
    Radiology. 1997 Jan;202(1):159-65.
  • Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, Servadio G, Rizzatto G, Mueller PR, Del Maschio A, Gazelle GS.
    Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.
    Radiology. 1997 Jan;202(1):195-203.
  • Trubetskoy VS, Gazelle GS, Wolf GL, Torchilin VP.
    Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography.
    J Drug Target. 1997;4(6):381-8.
  • Graf O, Gazelle GS, Kreuzer S, Halpern EF, Boehm P, Lechner G, Mueller PR.
    Enhancement of hepatic parenchyma, aorta, and portal vein in helical CT: comparison of iodixanol and iopromide.
    AJR Am J Roentgenol. 1997 Jan;168(1):213-7.
  • Livraghi T, Goldberg SN, Monti F, Bizzini A, Lazzaroni S, Meloni F, Pellicanň S, Solbiati L, Gazelle GS.
    Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases.
    Radiology. 1997 Jan;202(1):205-10.
  • Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC.
    Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung.
    Acad Radiol. 1996 Nov;3(11):929-35.
  • Wolf GL, Gazelle GS, Hamberg L, Hunter G, Rogowska J, Jiang D, Leong F.
    Functional computed tomography scanning with radiopaque agents: applications in the brain, kidney, and tumor of small and large mammals.
    Acad Radiol. 1996 Aug;3 Suppl 2:S376-8.
  • Gervais DA, Gazelle GS, Lu DS, Han PF, Mueller PR.
    Percutaneous transpulmonary CT-guided liver biopsy: a safe and technically easy approach for lesions located near the diaphragm.
    AJR Am J Roentgenol. 1996 Aug;167(2):482-3.
  • Hamberg LM, Hunter GJ, Halpern EF, Hoop B, Gazelle GS, Wolf GL.
    Quantitative high-resolution measurement of cerebrovascular physiology with slip-ring CT.
    AJNR Am J Neuroradiol. 1996 Apr;17(4):639-50.
  • Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI.
    Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size.
    Acad Radiol. 1996 Mar;3(3):212-8.
  • Jiang DY, Gazelle GS, Wolf GL.
    A model of focal cancer in rabbit lymph nodes.
    Acad Radiol. 1996 Feb;3(2):159-62.
  • Lee MJ, Mueller PR, Dawson SL, Gazelle SG, Hahn PF, Goldberg MA, Boland GW.
    Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy.
    AJR Am J Roentgenol. 1995 Jan;164(1):215-20.